Verastem, Inc. (VSTM) stock
VSTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.41−0.29 (-3.77%)
Close on Nov 17, 2026Market cap $671.08MP/E –Yield –
Verastem total assets
Total assets on the balance sheet at the end of each period.
Verastem's total assets was $206.51M at Jun 30, 2026. For fiscal 2025 it was $246.44M, up 142.7% from the year before. Over ten years it grew 8.1% a year on average. The highest annual figure on record is $277.24M in fiscal 2018.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $246.44M | +142.7% |
| FY2024 | Dec 31, 2024 | $101.54M | -32.2% |
| FY2023 | Dec 31, 2023 | $149.72M | +57.5% |
| FY2022 | Dec 31, 2022 | $95.05M | -12.5% |
| FY2021 | Dec 31, 2021 | $108.66M | -29.6% |
| FY2020 | Dec 31, 2020 | $154.35M | +6.4% |
| FY2019 | Dec 31, 2019 | $145.05M | -47.7% |
| FY2018 | Dec 31, 2018 | $277.24M | +208.8% |
| FY2017 | Dec 31, 2017 | $89.79M | +7.4% |
| FY2016 | Dec 31, 2016 | $83.63M | -26.1% |
| FY2015 | Dec 31, 2015 | $113.09M | +14.6% |
| FY2014 | Dec 31, 2014 | $98.65M | -21.2% |
| FY2013 | Dec 31, 2013 | $125.26M | +34.8% |
| FY2012 | Dec 31, 2012 | $92.92M | +57.4% |
| FY2011 | Dec 31, 2011 | $59.04M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $206.51M | +5.2% |
| Q1 FY2026 | Mar 31, 2026 | $227.81M | +73.0% |
| Q4 FY2025 | Dec 31, 2025 | $246.44M | +142.7% |
| Q3 FY2025 | Sep 30, 2025 | $176.85M | +39.9% |
| Q2 FY2025 | Jun 30, 2025 | $196.26M | +85.6% |
| Q1 FY2025 | Mar 31, 2025 | $131.70M | -12.0% |
| Q4 FY2024 | Dec 31, 2024 | $101.54M | -42.4% |
| Q3 FY2024 | Sep 30, 2024 | $126.38M | -34.1% |
| Q1 FY2024 | Jun 30, 2024 | $105.75M | -12.5% |
| Q4 FY2023 | Dec 31, 2023 | $149.72M | +57.5% |
| Q3 FY2023 | Sep 30, 2023 | $176.15M | +58.6% |
| Q2 FY2023 | Jun 30, 2023 | $191.76M | +91.0% |
| Q1 FY2023 | Mar 31, 2023 | $120.88M | +4.1% |
| Q4 FY2022 | Dec 31, 2022 | $95.05M | -12.5% |
| Q3 FY2022 | Sep 30, 2022 | $111.10M | -0.7% |
| Q2 FY2022 | Jun 30, 2022 | $100.41M | -19.0% |
| Q1 FY2022 | Mar 31, 2022 | $116.15M | -15.2% |
| Q4 FY2021 | Dec 31, 2021 | $108.66M | -29.6% |
| Q3 FY2021 | Sep 30, 2021 | $111.88M | -48.6% |
| Q2 FY2021 | Jun 30, 2021 | $123.89M | -37.6% |
| Q1 FY2021 | Mar 31, 2021 | $136.90M | -34.2% |
| Q4 FY2020 | Dec 31, 2020 | $154.35M | +6.4% |
| Q3 FY2020 | Sep 30, 2020 | $217.77M | +13.1% |
| Q2 FY2020 | Jun 30, 2020 | $198.53M | -9.2% |
| Q1 FY2020 | Mar 31, 2020 | $208.15M | -14.5% |
| Q4 FY2019 | Dec 31, 2019 | $145.05M | -47.7% |
| Q3 FY2019 | Sep 30, 2019 | $192.60M | +5.2% |
| Q2 FY2019 | Jun 30, 2019 | $218.54M | +26.4% |
| Q1 FY2019 | Mar 31, 2019 | $243.37M | +255.7% |
| Q4 FY2018 | Dec 31, 2018 | $277.24M | +208.8% |
| Q3 FY2018 | Sep 30, 2018 | $183.16M | +190.1% |
| Q2 FY2018 | Jun 30, 2018 | $172.92M | +179.6% |
| Q1 FY2018 | Mar 31, 2018 | $68.41M | -10.3% |
| Q4 FY2017 | Dec 31, 2017 | $89.79M | +7.4% |
| Q3 FY2017 | Sep 30, 2017 | $63.14M | -29.1% |
| Q2 FY2017 | Jun 30, 2017 | $61.84M | -35.2% |
| Q1 FY2017 | Mar 31, 2017 | $76.25M | – |
| Q4 FY2016 | Dec 31, 2016 | $83.63M | – |
| Q3 FY2016 | Sep 30, 2016 | $89.04M | – |
| Q2 FY2016 | Jun 30, 2016 | $95.42M | – |
See a number that looks wrong?